Bukwang Pharm (003000) — Cash Flow Quality Index
Bukwang Pharm (003000) has a Cash Flow Quality Index of -4.08x as of September 2025. Operating cash flow of ₩-6.24 Billion is below net income of ₩1.53 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Bukwang Pharm debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bukwang Pharm Cash Flow Quality Index (2007–2018)
Historical Cash Flow Quality Index for Bukwang Pharm across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Bukwang Pharm generate cash.
Annual Cash Flow Quality Index for Bukwang Pharm (2007–2018)
Year-by-year earnings quality comparison for Bukwang Pharm.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 0.05x | ₩6.82 Billion | ₩145.67 Billion | ▼ -93.9% |
| 2017 | 0.77x | ₩8.56 Billion | ₩11.09 Billion | ▲ +257.2% |
| 2016 | -0.49x | ₩-7.76 Billion | ₩15.81 Billion | ▼ -219.9% |
| 2015 | 0.41x | ₩10.30 Billion | ₩25.14 Billion | ▼ -65.3% |
| 2014 | 1.18x | ₩27.86 Billion | ₩23.62 Billion | ▼ -36.9% |
| 2013 | 1.87x | ₩36.52 Billion | ₩19.53 Billion | ▲ +120.1% |
| 2007 | 0.85x | ₩27.87 Billion | ₩32.82 Billion | — |